Pulmonx Corp (LUNG) Company Profile & Statistics

Pulmonx Corp
LUNG
(Nasdaq - US)
N/A
9.54
+0.26 (+2.80%)
in:usd•As of: May 07, 2024 15:59 UTC -4
Open
9.31
High
9.74
Low
9.29

About Pulmonx Corp

CEO

Glendon E. French

Headquarters

700 chesapeake drive

redwood city, ca 94063, united states

Auditor

BDO USA, P.C.

Employees

279

Share Holders

136

Website

www.pulmonx.com

Industry

medical specialties

Sector

health technology

Company Overview

Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California.

Pulmonx Corp Statistics

Valuation Measures

Market Capitalization ²	367.67M
Enterprise Value	334.51M
Enterprise Value/EBITDA (ttm)	-5.60
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	3.18
Price to Sales (ttm)	5.18
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	74.29%
Operating Margin (ttm)	-80.46%
Profit Margin (ttm)	-80.87%
Return on Equity (ttm)	-46.61%
Return on Invested Capital (ttm)	-37.31%
Return on Assets (ttm)	-31.69%

Income Statement

Revenue (ttm)	72.99M
Revenue Per Share (ttm)	1.88
Gross Profit (ttm)	54.24M
EBITDA (ttm)³	-59.70M
Net Income Avi to Common (ttm)	-58.73M
Diluted EPS (ttm)	-1.54

Share Statistics

Beta (5Y Monthly)	0.66
52-Week Change	-23.25%
S&P500 52-Week Change	27.90%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	38.82M
Dividend Yield	0.00%
Float ⁴	36.34M
% Held by Insiders	5.70%
% Held by Institutions	91.04%

Balance Sheet

Total Cash (mrq)	116.37M
Total Cash Per Share (mrq)	3.00
Total Debt (mrq)	37.23M
Total Debt/Equity (mrq)	33.70%
Current Ratio (mrq)	6.95%
Quick Ratio (mrq)	5.77%
Book Value Per Share (mrq)	2.85

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.31
Free Cash Flow (ytd)	-12.25M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Pulmonx Corp

Trade With A Regulated Broker